Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:09 AM EST
318.20quote price arrow up+16.71 (+5.54%)
Volume
228,464
Close
301.49quote price arrow down-9.12 (-2.94%)
Volume
14,845,269
52 week range
102.66 - 497.49
Loading...
  • Open301.29
  • Day High318.47
  • Day Low291.03
  • Prev Close301.49
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap121.696B
  • Shares Out403.65M
  • 10 Day Average Volume13.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change188.59

KEY STATS

  • Open301.29
  • Day High318.47
  • Day Low291.03
  • Prev Close301.49
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low102.66
  • 52 Week Low Date12/31/20
  • Market Cap121.696B
  • Shares Out403.65M
  • 10 Day Average Volume13.74M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change188.59

RATIOS/PROFITABILITY

  • EPS (TTM)16.28
  • P/E (TTM)18.52
  • Fwd P/E (NTM)6.85
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date02/23/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:3203:32
Three-dose vaccine regimen is the world's path out of omicron: Singapore doctor

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
333.49-0.99-0.30%
REGN
Regeneron Pharmaceuticals Inc
634.00+3.41+0.54%
BIIB
Biogen Inc
228.52-0.98-0.43%
ILMN
Illumina Inc
357.48-0.18-0.05%
SYNH
Syneos Health Inc
98.65+2.16+2.24%